Zoetis Reports First-Quarter 2013 Results
US - Zoetis, formerly the animal health business of Pfizer Inc., has reported its financial results for...
European Pig Meat Industry Facing Its Challenges
EU - The European pig meat industry is facing its challenges with issues such as regulations on sow pens...
Zoetis Looks to the Future
GLOBAL - Zoetis is the new name for Pfizer Animal Health following an initial public offering (IPO) on...
Growing Importance of Emerging Markets
GLOBAL - The emerging markets are becoming an increasingly important focus for global companies, according...
DRAXXINFor a complete listing of Pfizer pork products, go to PfizerPork.com
EXCEDE For Swine
RESPISURE/ RESPISURE ONE
AUREO S-P 250
Individual Pig Care - It's The Right Thing To Do.
Health and Performance Improvements of Pigs Treated with DRAXXIN® (tulathromycin) Injectable Solution for Swine Respiratory Disease Under Field Conditions
Performance and Health Improvements of Pigs Treated with DRAXXIN® (tulathromycin) Injectable Solution: A Mycoplasma hyopneumoniae Challenge Model
FluSure XP™: Research-Backed Swine Influenza Virus (SIV) Vaccine for Combating Rapidly Evolving SIV Viruses
What's New With Swine Flu?
By Michael Kuhn, DVM, Pfizer Animal Health.
FarrowSure® GOLD B: Profiling efficacy and safety of a new, reformulated 2-mL dose vaccine
Clinical and economic effects of lincomycin in-feed (Lincomix®) and/or a porcine proliferative enteropathy (ileitis) vaccine (Enterisol® Ileitis) in pigs challenged with Lawsonia intracellularis
Comparative study demonstrates RespiSure® reduces clinical signs, lung lesions, and production losses in swine co-infected with M. hyopneumoniae and PCV2
Draxxin® (tulathromycin) Injectable Solution: Duration of effectiveness in an Actinobacillus pleuropneumoniae challenge model
Product Information contained on this page applies to the United States only.
For other countries please refer to your local representatives.